Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.

NCT02153645 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease
Levodopa Induced Dyskinesias (LID)

Interventions

DRUG: 240mg Amantadine HCl ER tablets
DRUG: Placebo tablets
DRUG: 320mg Amantadine HCl ER tablets

Sponsor

Adamas Pharmaceuticals, Inc.